Charlotte, NC – QC Kinetix has announced the appointment of Peter Holt as Chief Executive Officer. About QC Kinetix: QC Kinetix is a leading regenerative medicine provider specializing in non-surgical treatments for joint pain and musculoskeletal conditions, utilizing advanced biologic therapies to help patients avoid surgery and opioids. The company operates a rapidly expanding network of clinics across the United States, focusing on personalized, cutting-edge protocols that promote natural healing through the body’s own repair mechanisms. QC Kinetix has distinguished itself in the healthcare industry by prioritizing patient outcomes and innovation in regenerative medicine, earning recognition for its high success rates in treating chronic pain without invasive procedures. On April 14, 2026, the company announced the appointment of Peter Holt, former CEO of The Joint Corp., as its new CEO to spearhead the next phase of national growth and scale its footprint further. This strategic leadership move underscores QC Kinetix’s commitment to accelerating expansion while maintaining its position as a pioneer in accessible, biology-based pain relief solutions.

For more information on QC Kinetix please visit: https://qckinetix.com/

QC Kinetix
227 W Trade St Suite 2160
Charlotte, NC 28202
Phone: 866-858-8690
LinkedIn Page: https://www.linkedin.com/company/qckinetix-corporate/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved